Uncategorized
UMA, hospital to develop medical campus in west Omaha
University Medical Associates and its partners, The Nebraska Medical Center and UNMC, are planning to develop a comprehensive, full-service medical campus on the southeast corner of 180th and Dodge Streets, just west of the new Village Pointe shopping area.
Jul 23, 2004
University Medical Associates and The Nebraska Medical Center to develop comprehensive medical campus near 180th & Dodge Streets
University Medical Associates and its partners, The Nebraska Medical Center and the University of Nebraska Medical Center, are planning to develop a comprehensive, full-service medical campus on the southeast corner of 180th and Dodge Streets, just west of the new Village Pointe shopping area. The West Omaha medical campus will be a key component of […]
Jul 23, 2004
Dr. Boust mental health care champion
Psychiatrist Susan Boust, M.D., has been appointed to the newly established state Behavioral Health and Oversight Commission. An associate professor of psychiatry at UNMC, Dr. Boust has long been a champion of the need for better public access to quality mental health care.
Jul 22, 2004
Cancer experts to participate in July 28 Internet chat
Three cancer experts from UNMC will conduct a live Internet chat sponsored by the American Society of Clinical Oncology’s patient Web site, People Living With Cancer (www.PLWC.org). The live chat will be Wednesday, July 28, from 1 to 2 p.m. (CDT) on “Understanding Leukemia, Lymphoma, and Myeloma.” The chat will provide patients, family members and caregivers an opportunity to ask questions of experts.
Jul 22, 2004
A weekly IRB message — protocol deviations
Each Wednesday, UNMC Today features an informational article about changes affecting UNMC’s Institutional Review Board (IRB) and the research community. This week’s IRB message will discuss protocol deviations.
Jul 21, 2004
Online service helps support UNMC researcher
Verlyn Veldhouse politely listened to Sandra Gunselman, Ph.D., as she spoke about her job at UNMC whenever they met at their sons’ Boy Scout meetings. Dr. Gunselman didn’t know if she was boring Veldhouse with the small talk. “He never really said anything,” she said, until last December when Veldhouse, president of the Omaha-based Internet service efanz, approached Dr. Gunselman and offered a $2,000 donation toward her research.
Jul 21, 2004
Lotus Notes users – Clarkson e-mail to change July 27
If you use Lotus Notes to send e-mail messages to The Nebraska Medical Center hospital or clinics, ITS says be aware of the following:
- Beginning July 27, the Clarkson e-mail address will change to The Nebraska Medical Center and replies to old messages with the Clarkson address will be undeliverable, requiring you to use the new address.
- Personal address book groups will need to be updated with the new address, beginning July 27 (see story for instructions). Timing is crucial so don’t update too soon.
Jul 21, 2004
Local students make UNMC College of Nursing dean’s list
Students from the University of Nebraska Medical Center College of Nursing were named to the deans list following the spring semester 2004. To qualify for the deans list, students must have a grade point average of 3.5 or above. The UNMC College of Nursing, based in Omaha, with divisions in Lincoln, Kearney and Scottsbluff, is […]
Jul 20, 2004
UNMC-led international anti-malarial drug discovery progresses to first phase of human trials
A University of Nebraska Medical Center College of Pharmacy-led team of scientists is celebrating with cautious optimism as the drug it developed has taken another step toward success. The anti-malarial drug candidate is now being tested in phase I clinical trials in London, where it is being evaluated for safety in a small group of […]
Jul 20, 2004
UNMC-led international anti-malarial drug discovery progresses to first phase of human trials
A University of Nebraska Medical Center College of Pharmacy-led team of scientists is celebrating with cautious optimism as the drug it developed has taken another step toward success. The anti-malarial drug candidate is now being tested in phase I clinical trials in London, where it is being evaluated for safety in a small group of […]
Jul 20, 2004